Transcriptional Factor Yin Yang 1 Promotes the Stemness of Breast Cancer Cells by Suppressing miR-873-5p Transcriptional Activity

被引:30
作者
Guo, Qianqian [2 ]
Wang, Ting [1 ]
Yang, Yue [1 ]
Gao, Lanlan [1 ]
Zhao, Qiong [1 ]
Zhang, Wenzhou [2 ]
Xi, Tao [1 ]
Zheng, Lufeng [1 ]
机构
[1] China Pharmaceut Univ, Sch Life Sci & Technol, Jiangsu Key Lab Carcinogenesis & Intervent, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China
[2] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Pharm, 127 Dongming Rd, Zhengzhou 450003, Peoples R China
基金
中国国家自然科学基金;
关键词
GENE-EXPRESSION; FACTOR YY1; TUMOR-GROWTH; B-NHL; TUMORIGENESIS; METHYLATION; PROTEIN; PROLIFERATION; RESISTANCE; BRCA1;
D O I
10.1016/j.omtn.2020.06.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Transcription factor Yin Yang 1 (YY1) is upregulated in multiple tumors and plays essential roles in tumor proliferation and metastasis. However, the function of YY1 in breast cancer stemness remains unclear. Herein, we found that YY1 expression was negatively correlated with the overall survival and relapse-free survival of breast cancer patients and positively correlated with the expression of stemness markers in breast cancer. Overexpression of YY1 increased the expression of stemness markers, elevated CD44+CD24- cell sub-population, and enhanced the capacity of cell spheroid formation and tumor-initiation. In contrast, YY1 knockdown exhibited the opposite effects. Mechanistically, YY1 decreased microRNA-873-5p (miR-873-5p) level by recruiting histone deacetylase 4 (HDAC4) and HDAC9 to miR-873-5p promoter and thus increasing the deacetylation level of miR-873-5p promoter. Sequentially, YY1 activated the downstream PI3K/AKT and ERK1/2 pathways, which have been confirmed to be suppressed by miR-873-5p in our recent work. Moreover, the suppressed effect of YY1/miR-873-5p axis on the stemness of breast cancer cells was partially dependent on PI3K/AKT and ERK1/2 pathways. Finally, it was found that the YY1/miR-873-5p axis is involved in the chemoresistance of breast cancer cells. Our study defines a novel YY1/miR-873-5p axis responsible for the stemness of breast cancer cells.
引用
收藏
页码:527 / 541
页数:15
相关论文
共 56 条
[1]   The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors [J].
Allouche, Abdelkader ;
Nolens, Gregory ;
Tancredi, Annalisa ;
Delacroix, Laurence ;
Mardaga, Julie ;
Fridman, Viviana ;
Winkler, Rosita ;
Boniver, Jacques ;
Delvenne, Philippe ;
Begon, Dominique Y. .
BREAST CANCER RESEARCH, 2008, 10 (01)
[2]   PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation [J].
Almozyan, Sheema ;
Colak, Dilek ;
Mansour, Fatmah ;
Alaiya, Ayodele ;
Al-Harazi, Olfat ;
Qattan, Amal ;
Al-Mohanna, Falah ;
Al-Alwan, Monther ;
Ghebeh, Hazem .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (07) :1402-1412
[3]   Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells [J].
Begon, DY ;
Delacroix, L ;
Vernimmen, D ;
Jackers, P ;
Winkler, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) :24428-24434
[4]   An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors [J].
Ben-Porath, Ittai ;
Thomson, Matthew W. ;
Carey, Vincent J. ;
Ge, Ruping ;
Bell, George W. ;
Regev, Aviv ;
Weinberg, Robert A. .
NATURE GENETICS, 2008, 40 (05) :499-507
[5]   Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity [J].
Bonuccelli, Gloria ;
Peiris-Pages, Maria ;
Ozsvari, Bela ;
Martinez-Outschoorn, Ubaldo E. ;
Sotgia, Federica ;
Lisanti, Michael P. .
ONCOTARGET, 2017, 8 (06) :9868-9884
[6]   Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis [J].
Celia-Terrassa, Toni ;
Liu, Daniel D. ;
Choudhury, Abrar ;
Hang, Xiang ;
Wei, Yong ;
Zamalloa, Jose ;
Alfaro-Aco, Raymundo ;
Chakrabarti, Rumela ;
Jiang, Yi-Zhou ;
Koh, Bong Ihn ;
Smith, Heath A. ;
DeCoste, Christina ;
Li, Jun-Jing ;
Shao, Zhi-Ming ;
Kang, Yibin .
NATURE CELL BIOLOGY, 2017, 19 (06) :711-+
[7]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[8]   MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells (vol 34, pg 3895, 2015) [J].
Cui, J. ;
Yang, Y. ;
Li, H. ;
Leng, Y. ;
Qian, K. ;
Huang, Q. ;
Zhang, C. ;
Lu, Z. ;
Chen, J. ;
Sun, T. ;
Wu, R. ;
Sun, Y. ;
Song, H. ;
Wei, X. ;
Jing, P. ;
Yang, X. ;
Zhang, C. .
ONCOGENE, 2015, 34 (30) :4018-4018
[9]  
Felekkis K, 2010, HIPPOKRATIA, V14, P236
[10]   MiR-873/PD-L1 axis regulates the stemness of breast cancer cells [J].
Gao, Lanlan ;
Guo, Qianqian ;
Li, Xiaoman ;
Yang, Xuan ;
Ni, Haiwei ;
Wang, Ting ;
Zhao, Qiong ;
Liu, Hai ;
Xing, Yingying ;
Xi, Tao ;
Zheng, Lufeng .
EBIOMEDICINE, 2019, 41 :395-407